Stay updated with breaking news from Huma hassan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hamilton Lane Advisors LLC trimmed its holdings in shares of Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 58.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 21,893 shares of the company’s stock after selling 30,800 shares during the period. Humacyte […] ....
Web Series News: Riding on the success of "Tarla" and "Monica O My Darling," Huma Qureshi gears up for the third season of "Maharani," unveiling a gripping teaser. Her ....
Humacyte (NASDAQ:HUMA – Get Free Report) and Avalon GloboCare (NASDAQ:ALBT – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends. Volatility and Risk Humacyte has a beta of […] ....
Humacyte (NASDAQ:HUMA – Free Report) had its price target cut by Benchmark from $16.00 to $15.00 in a research report report published on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages also recently weighed in on HUMA. Piper Sandler lowered their price objective on shares […] ....
Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) was the recipient of a significant growth in short interest in November. As of November 15th, there was short interest totalling 6,090,000 shares, a growth of 10.7% from the October 31st total of 5,500,000 shares. Based on an average daily trading volume, of 583,200 shares, the short-interest ratio […] ....